All Stories

  1. Identifying and understanding factors that affect the translation of therapies from the laboratory to patients: a study protocol
  2. Real-world Independent Testing of e-ASPECTS Software (RITeS): statistical analysis plan
  3. Systematic review of guidelines for internal validity in the design, conduct and analysis of preclinical biomedical experiments involving laboratory animals
  4. Effects of antiplatelet therapy on stroke risk by brain imaging features of intracerebral haemorrhage and cerebral small vessel diseases: subgroup analyses of the RESTART randomised, open-label trial
  5. Extending thrombolysis to 4·5–9 h and wake-up stroke using perfusion imaging: a systematic review and meta-analysis of individual patient data
  6. A randomised controlled trial of an Intervention to Improve Compliance with the ARRIVE guidelines (IICARus)
  7. Outcome heterogeneity and bias in acute experimental spinal cord injury
  8. Effects of antiplatelet therapy after stroke due to intracerebral haemorrhage (RESTART): a randomised, open-label trial
  9. Animal models of chemotherapy-induced peripheral neuropathy: A machine-assisted systematic review and meta-analysis
  10. Thrombolysis Guided by Perfusion Imaging up to 9 Hours after Onset of Stroke
  11. Administration of galacto-oligosaccharide prebiotics in the Flinders Sensitive Line animal model of depression
  12. Protocol for a systematic review and meta-analysis of data from preclinical studies employing forced swimming test: an update
  13. Towards minimum reporting standards for life scientists
  14. Therapeutic hypothermia for acute ischaemic stroke. Results of a European multicentre, randomised, phase III clinical trial
  15. A European initiative to unclog pipeline for new medicines
  16. The development and evaluation of an online application to assist in the extraction of data from graphs for use in systematic reviews
  17. The development and evaluation of an online application to assist in the extraction of data from graphs for use in systematic reviews
  18. Machine learning algorithms for systematic review: reducing workload in a preclinical review of animal studies and reducing human screening error
  19. Identifying stroke therapeutics from preclinical models: A protocol for a novel application of network meta-analysis
  20. Effects of fluoxetine on functional outcomes after acute stroke (FOCUS): a pragmatic, double-blind, randomised, controlled trial
  21. The development and evaluation of an online application to assist in the extraction of data from graphs for use in systematic reviews
  22. Potentially serious incidental findings on brain and body magnetic resonance imaging of apparently asymptomatic adults: systematic review and meta-analysis
  23. Protocol for a systematic review of guidelines for rigour in the design, conduct and analysis of biomedical experiments involving laboratory animals
  24. The reproducibility opportunity
  25. NXY-059, a Failed Stroke Neuroprotectant, Offers No Protection to Stem Cell-Derived Human Neurons
  26. A randomised controlled trial of an Intervention to Improve Compliance with the ARRIVE guidelines (IICARus)
  27. PRECIOUS: PREvention of Complications to Improve OUtcome in elderly patients with acute Stroke. Rationale and design of a randomised, open, phase III, clinical trial with blinded outcome assessment
  28. Small vessels, dementia and chronic diseases – molecular mechanisms and pathophysiology
  29. Effect size and statistical power in the rodent fear conditioning literature – A systematic review
  30. The use of text-mining and machine learning algorithms in systematic reviews: reducing workload in preclinical biomedical sciences and reducing human screening error
  31. A systematic review and meta-analysis of topoisomerase inhibition in pre-clinical glioma models
  32. Facilitating healthcare decisions by assessing the certainty in the evidence from preclinical animal studies
  33. Learning lessons from MVA85A, a failed booster vaccine for BCG
  34. Transparency in the reporting of in vivo pre-clinical pain research: The relevance and implications of the ARRIVE (Animal Research: Reporting In Vivo Experiments) guidelines
  35. Statistical analysis plan for the EuroHYP-1 trial: European multicentre, randomised, phase III clinical trial of the therapeutic hypothermia plus best medical treatment versus best medical treatment alone for acute ischaemic stroke
  36. Identification and characterization of outcome measures reported in animal models of epilepsy: Protocol for a systematic review of the literature-A TASK2 report of the AES/ILAE Translational Task Force of the ILAE
  37. Living systematic reviews: 2. Combining human and machine effort
  38. Living systematic reviews: 3. Statistical methods for updating meta-analyses
  39. Living systematic reviews: 4. Living guideline recommendations
  40. Risk of bias reporting in the recent animal focal cerebral ischaemia literature
  41. Marine-derived n-3 fatty acids therapy for stroke
  42. The Experimental Design Assistant
  43. The Experimental Design Assistant
  44. Findings of a retrospective, controlled cohort study of the impact of a change in Nature journals' editorial policy for life sciences research on the completeness of reporting study design and execution
  45. Standardized mean differences cause funnel plot distortion in publication bias assessments
  46. Living systematic review: 1. Introduction—the why, what, when, and how
  47. D-galactose-induced brain ageing model: A systematic review and meta-analysis on cognitive outcomes and oxidative stress indices
  48. Development of a psychological intervention for fatigue after stroke
  49. The IMPROVE Guidelines (Ischaemia Models: Procedural Refinements Of in Vivo Experiments)
  50. Alpha Calcitonin Gene-Related Peptide Increases Cerebral Vessel Diameter in Animal Models of Subarachnoid Hemorrhage: A Systematic Review and Meta-analysis
  51. Increasing value and reducing waste in stroke research
  52. Conjugal amyotrophic lateral sclerosis: a case report from Scotland
  53. Effect size and statistical power in the rodent fear conditioning literature - a systematic review
  54. Evolution of ischemic damage and behavioural deficit over 6 months after MCAo in the rat: Selecting the optimal outcomes and statistical power for multi-centre preclinical trials
  55. No publication without confirmation
  56. Hypothermia revisited: Impact of ischaemic duration and between experiment variability
  57. Protocol for a systematic review and meta-analysis of experimental models of amyotrophic lateral sclerosis
  58. Understanding in vivo modelling of depression in non-human animals: a systematic review protocol
  59. Protocols for laboratory research
  60. Evaluating mesenchymal stem cell therapy for sepsis with preclinical meta-analyses prior to initiating a first-in-human trial
  61. The Devil Is in the Details: Incomplete Reporting in Preclinical Animal Research
  62. Study protocol - A systematic review and meta-analysis of hypothermia in experimental traumatic brain injury: Why have promising animal studies not been replicated in pragmatic clinical trials?
  63. Multicenter Evaluation of Geometric Accuracy of MRI Protocols Used in Experimental Stroke
  64. Systematic Review and Meta-Analysis of the Efficacy of Interleukin-1 Receptor Antagonist in Animal Models of Stroke: an Update
  65. The Efficacy of Trastuzumab in Animal Models of Breast Cancer: A Systematic Review and Meta-Analysis
  66. A proposed framework for the systematic review and integrated assessment (SYRINA) of endocrine disrupting chemicals
  67. Failed trials for central nervous system disorders do not necessarily invalidate preclinical models and drug targets
  68. Olfactory Ensheathing Cell Transplantation in Experimental Spinal Cord Injury: Effect size and Reporting Bias of 62 Experimental Treatments: A Systematic Review and Meta-Analysis
  69. SWIFT-Review: a text-mining workbench for systematic review
  70. Protocol for a retrospective, controlled cohort study of the impact of a change in Nature journals’ editorial policy for life sciences research on the completeness of reporting study design and execution
  71. Cause of Death and Predictors of All‐Cause Mortality in Anticoagulated Patients With Nonvalvular Atrial Fibrillation: Data From ROCKET AF
  72. Cardiac Stem Cell Treatment in Myocardial InfarctionNovelty and Significance
  73. Corrigendum to ‘Meta-analysis of data from animal studies: A practical guide’
  74. How to Avoid Bumping into the Translational Roadblock
  75. AVERT 2 (a very early rehabilitation trial, a very effective reproductive trigger): retrospective observational analysis of the number of babies born to trial staff
  76. Effect of alteplase on the CT hyperdense artery sign and outcome after ischemic stroke
  77. Correction: Risk of Bias in Reports of In Vivo Research: A Focus for Improvement
  78. Informatics: Make sense of health data
  79. How individual participant data meta-analyses have influenced trial design, conduct, and analysis
  80. Translational failure of anti-inflammatory compounds for myocardial infarction: a meta-analysis of large animal models
  81. Risk of Bias in Reports of In Vivo Research: A Focus for Improvement
  82. The Clots in Legs Or sTockings after Stroke (CLOTS) 3 trial: a randomised controlled trial to determine whether or not intermittent pneumatic compression reduces the risk of post-stroke deep vein thrombosis and to estimate its cost-effectiveness
  83. Consent for Brain Tissue Donation after Intracerebral Haemorrhage: A Community-Based Study
  84. Exploring threats to generalisability in a large international rehabilitation trial (AVERT)
  85. Interventions for post-stroke fatigue
  86. Efficacy and safety of very early mobilisation within 24 h of stroke onset (AVERT): a randomised controlled trial
  87. Effect of Endothelin Receptor Antagonists on Clinically Relevant Outcomes after Experimental Subarachnoid Hemorrhage: A Systematic Review and Meta-Analysis
  88. Prof Benchie and Dr Athena-A modern tragedy…
  89. Increasing value and reducing waste in animal models of rheumatological disease
  90. Drug Repurposing: A Systematic Approach to Evaluate Candidate Oral Neuroprotective Interventions for Secondary Progressive Multiple Sclerosis
  91. Antiplatelet treatment compared with anticoagulation treatment for cervical artery dissection (CADISS): a randomised trial
  92. Experimental design and reporting standards for improving the internal validity of pre-clinical studies in the field of pain: Consensus of the IMI-Europain consortium
  93. Uptake of systematic reviews and meta-analyses based on individual participant data in clinical practice guidelines: descriptive study
  94. Magnetic Resonance Imaging in Experimental Stroke and Comparison With Histology
  95. Model of Understanding Fatigue After Stroke
  96. Influence of Intracerebral Hemorrhage Location on Incidence, Characteristics, and Outcome
  97. A systematic review and meta‐analysis of gene therapy in animal models of cerebral glioma: why did promise not translate to human therapy?
  98. Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: A systematic review and meta-analysis
  99. Effect of intermittent pneumatic compression on disability, living circumstances, quality of life, and hospital costs after stroke: secondary analyses from CLOTS 3, a randomised trial
  100. Similar Effect of Autologous and Allogeneic Cell Therapy for Ischemic Heart Disease: Systematic Review and Meta-Analysis of Large Animal Studies
  101. Efficacy of Antidepressants in Animal Models of Ischemic Stroke: A Systematic Review and Meta-Analysis
  102. Preclinical research: Design animal studies better
  103. Efficacy and Safety of Rivaroxaban Compared With Warfarin Among Elderly Patients With Nonvalvular Atrial Fibrillation in the Rivaroxaban Once Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embol...
  104. EuroHYP-1: European Multicenter, Randomized, Phase III Clinical Trial of Therapeutic Hypothermia plus Best Medical Treatment vs. Best Medical Treatment Alone for Acute Ischemic Stroke
  105. End-of-life decisions in patients with severe acute brain injury
  106. Psychological Associations of Poststroke Fatigue: A Systematic Review and Meta-Analysis
  107. Using Animal Models to Understand Cancer Pain in Humans
  108. Outcome After Conservative Management or Intervention for Unruptured Brain Arteriovenous Malformations
  109. Clopidogrel Plus Aspirin Versus Warfarin in Patients With Stroke and Aortic Arch Plaques
  110. Research: increasing value, reducing waste – Authors' reply
  111. Systematic Reviews and Meta-Analysis of Preclinical Studies: Why Perform Them and How to Appraise Them Critically
  112. Exercise Reduces Infarct Volume and Facilitates Neurobehavioral Recovery
  113. Therapeutic Hypothermia and the Risk of Infection
  114. A (mini) pill for stroke?
  115. Some Salt with Your Statin, Professor?
  116. Hypothermia Protects Human Neurons
  117. Systematic Review and Meta-Analysis of Interventions Tested in Animal Models of Lacunar Stroke
  118. Meta-analysis of data from animal studies: A practical guide
  119. Increasing value and reducing waste in research design, conduct, and analysis
  120. Increasing value and reducing waste in biomedical research regulation and management
  121. Effect and Reporting Bias of RhoA/ROCK-Blockade Intervention on Locomotor Recovery After Spinal Cord Injury
  122. Biomedical research: increasing value, reducing waste
  123. Efficacy and safety of mesenchymal stromal cells in preclinical models of acute lung injury: a systematic review protocol
  124. Stem Cell Transplantation in Traumatic Spinal Cord Injury: A Systematic Review and Meta-Analysis of Animal Studies
  125. Edoxaban versus Warfarin in Patients with Atrial Fibrillation
  126. Bringing rigour to translational medicine
  127. Edaravone Improves Functional and Structural Outcomes in Animal Models of Focal Cerebral Ischemia: A Systematic Review
  128. Meta-Analysis of Pre-Clinical Studies of Early Decompression in Acute Spinal Cord Injury: A Battle of Time and Pressure
  129. Systematic Review and Meta-Analysis of Therapeutic Hypothermia in Animal Models of Spinal Cord Injury
  130. Effectiveness of intermittent pneumatic compression in reduction of risk of deep vein thrombosis in patients who have had a stroke (CLOTS 3): a multicentre randomised controlled trial
  131. Evaluation of Excess Significance Bias in Animal Studies of Neurological Diseases
  132. Hypertension and Experimental Stroke Therapies
  133. Animal models of bone cancer pain: Systematic review and meta-analyses
  134. Systematic review and stratified meta-analysis of the efficacy of RhoA and Rho kinase inhibitors in animal models of ischaemic stroke
  135. Prevalence and natural history of pain in adults with multiple sclerosis: Systematic review and meta-analysis
  136. A Concerted Appeal for International Cooperation in Preclinical Stroke Research
  137. Evidence-based Translational Medicine
  138. Systematic review and meta-analysis of temozolomide in animal models of glioma: was clinical efficacy predicted?
  139. Role of multidetector computed tomography in the diagnosis and management of patients attending the rapid access chest pain clinic, The Scottish computed tomography of the heart (SCOT-HEART) trial: study protocol for randomized controlled trial
  140. A call for transparent reporting to optimize the predictive value of preclinical research
  141. Vorapaxar for secondary prevention of thrombotic events for patients with previous myocardial infarction: a prespecified subgroup analysis of the TRA 2°P-TIMI 50 trial
  142. The Benefit of Hypothermia in Experimental Ischemic Stroke is Not Affected by Pethidine
  143. Improving the Efficiency of the Development of Drugs for Stroke
  144. Translational Research
  145. Stem Cell-Based Therapy for Experimental Stroke: A Systematic Review and Meta-Analysis
  146. Voltage-gated potassium channel antibody-related encephalopathy: a case which may extend the documented phenotype of this condition
  147. The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial
  148. Antiplatelet therapy and the effects of B vitamins in patients with previous stroke or transient ischaemic attack: a post-hoc subanalysis of VITATOPS, a randomised, placebo-controlled trial
  149. Pharmacologic Reduction of Angiographic Vasospasm in Experimental Subarachnoid Hemorrhage: Systematic Review and Meta-Analysis
  150. Vorapaxar in the Secondary Prevention of Atherothrombotic Events
  151. Rivaroxaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of ROCKET AF
  152. Untreated clinical course of cerebral cavernous malformations: a prospective, population-based cohort study
  153. Evaluation of Combination Therapy in Animal Models of Cerebral Ischemia
  154. Update on the third international stroke trial (IST-3) of thrombolysis for acute ischaemic stroke and baseline features of the 3035 patients recruited
  155. The timing, extent, progression and regression of deep vein thrombosis in immobile stroke patients: observational data from the CLOTS multicenter randomized trials
  156. Preclinical studies of human disease: Time to take methodological quality seriously
  157. Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
  158. Why animal research needs to improve
  159. Sodium and chloride channelopathies with myositis: Coincidence or connection?
  160. Terutroban versus aspirin in patients with cerebral ischaemic events (PERFORM): a randomised, double-blind, parallel-group trial
  161. Dopamine agonists in animal models of Parkinson’s disease: A systematic review and meta-analysis
  162. Not Tonight, Darling, I Might Get a Headache
  163. Systematic Survey of the Design, Statistical Analysis, and Reporting of Studies Published in the 2008 Volume of the Journal of Cerebral Blood Flow and Metabolism
  164. Treatment of intracerebral hemorrhage in animal models: Meta-analysis
  165. Systematic Survey of the Design, Statistical Analysis, and Reporting of Studies Published in the 2008 Volume of theJournal of Cerebral Blood Flow and Metabolism
  166. Animal models of neurological disease: are there any babies in the bathwater?
  167. Hypothermia for Stroke: Call to Action 2010
  168. Preclinical Drug Evaluation for Combination Therapy in Acute Stroke Using Systematic Review, Meta-Analysis, and Subsequent Experimental Testing
  169. B vitamins in patients with recent transient ischaemic attack or stroke in the VITAmins TO Prevent Stroke (VITATOPS) trial: a randomised, double-blind, parallel, placebo-controlled trial
  170. Improving the translational hit of experimental treatments in multiple sclerosis
  171. Factors Affecting the Apparent Efficacy and Safety of Tissue Plasminogen Activator in Thrombotic Occlusion Models of Stroke: Systematic Review and Meta-Analysis
  172. Different Strokes for Different Folks: The Rich Diversity of Animal Models of Focal Cerebral Ischemia
  173. Comment on "Detection of an Infectious Retrovirus, XMRV, in Blood Cells of Patients with Chronic Fatigue Syndrome"
  174. Therapeutic Hypothermia for Acute Ischemic Stroke: Ready to Start Large Randomized Trials?
  175. Publication Bias in Reports of Animal Stroke Studies Leads to Major Overstatement of Efficacy
  176. Can Animal Models of Disease Reliably Inform Human Studies?
  177. How to Avoid Bumping into the Translational Roadblock
  178. A Systematic Review and Meta-Analysis of Erythropoietin in Experimental Stroke
  179. Emulating Multicentre Clinical Stroke Trials: A New Paradigm for Studying Novel Interventions in Experimental Models of Stroke
  180. Bacterial meningitis associated with a complex ischiorectal abscess
  181. Stroke research at a road block: the streets from adversity should be paved with meta-analysis and good laboratory practice
  182. Systematic Review and Stratified Meta-analysis of the Efficacy of Interleukin-1 Receptor Antagonist in Animal Models of Stroke
  183. Scope of Preclinical Testing Versus Quality Control Within Experiments
  184. Injury-induced mineralocorticoid receptor expression involves differential promoter usage: A novel role for the rat MRβ variant
  185. Effectiveness of thigh-length graduated compression stockings to reduce the risk of deep vein thrombosis after stroke (CLOTS trial 1): a multicentre, randomised controlled trial
  186. Reprint: Good Laboratory Practice: Preventing Introduction of Bias at the Bench
  187. Stroke Therapy Academic Industry Roundtable (STAIR) Recommendations for Extended Window Acute Stroke Therapy Trials
  188. Surgical decompression for space-occupying cerebral infarction (the Hemicraniectomy After Middle Cerebral Artery infarction with Life-threatening Edema Trial [HAMLET]): a multicentre, open, randomised trial
  189. Mineralocorticoid receptor mRNA expression is increased in human hippocampus following brief cerebral ischaemia
  190. Update of the Stroke Therapy Academic Industry Roundtable Preclinical Recommendations
  191. REPRINT: Good Laboratory Practice: Preventing Introduction of Bias at the Bench
  192. Effect of hyperthermia and anoxia on glucocorticoid and mineralocorticoid receptor expression in neonatal rat hippocampus
  193. Rationale and Design of a Randomized, Double-Blind, Parallel-Group Study of Terutroban 30 mg/day versus Aspirin 100 mg/day in Stroke Patients: The Prevention of Cerebrovascular and Cardiovascular Events of Ischemic Origin with Terutroban in Patients wi...
  194. General anaesthesia versus local anaesthesia for carotid surgery (GALA): a multicentre, randomised controlled trial
  195. The Future of Restorative Neurosciences in Stroke: Driving the Translational Research Pipeline From Basic Science to Rehabilitation of People After Stroke
  196. What is the translational efficacy of chemotherapeutic drug research in neuro-oncology? A systematic review and meta-analysis of the efficacy of BCNU and CCNU in animal models of glioma
  197. Reprint: Good Laboratory Practice: Preventing Introduction of Bias at the Bench
  198. Secondary prevention of stroke – Authors' reply
  199. Good Laboratory Practice: Preventing Introduction of Bias at the Bench
  200. Evidence for the Efficacy of NXY-059 in Experimental Focal Cerebral Ischaemia Is Confounded by Study Quality
  201. Stroke
  202. Predicting outcome in hyper-acute stroke: validation of a prognostic model in the Third International Stroke Trial (IST3)
  203. Outcome after interventional or conservative management of unruptured brain arteriovenous malformations: a prospective, population-based cohort study
  204. Empirical Evidence of Bias in the Design of Experimental Stroke Studies: A Metaepidemiologic Approach
  205. A Systematic Review and Meta-Analysis of the Efficacy of Piracetam and Piracetam-Like Compounds in Experimental Stroke
  206. How can we improve the pre-clinical development of drugs for stroke?
  207. Vanishing diplopia: a problem case
  208. Hypothermia in animal models of acute ischaemic stroke: a systematic review and meta-analysis
  209. Forebrain mineralocorticoid receptor overexpression enhances memory, reduces anxiety and attenuates neuronal loss in cerebral ischaemia
  210. Systematic Review and Meta-Analysis of the Efficacy of Tirilazad in Experimental Stroke
  211. Comparison of treatment effects between animal experiments and clinical trials: systematic review
  212. Hemicraniectomy after middle cerebral artery infarction with life-threatening Edema trial (HAMLET). Protocol for a randomised controlled trial of decompressive surgery in space-occupying hemispheric infarction
  213. Aortic Arch Atheroma
  214. 1,026 Experimental treatments in acute stroke
  215. Greater Incidence of Both Fatal and Nonfatal Strokes in Disadvantaged Areas: The Northeast Melbourne Stroke Incidence Study
  216. Current Issues in the Treatment of Acute Posterior Circulation Stroke
  217. Epilepsy update
  218. Surveying the literature from animal experiments: Systematic review and meta-analysis are important contributions
  219. Neuro-oncology for non-oncologists
  220. Overexpression of the mineralocorticoid receptor protects against injury in PC12 cells
  221. Systematic Review and Metaanalysis of the Efficacy of FK506 in Experimental Stroke
  222. Gender and deprivation and rates of referral and thereby admission to a national neurorehabilitation service
  223. Systematic review and meta-analysis of the efficacy of melatonin in experimental stroke
  224. Results of a Multicentre, Randomised Controlled Trial of Intra-Arterial Urokinase in the Treatment of Acute Posterior Circulation Ischaemic Stroke
  225. MicroRNA – Taking Regulation of Protein Synthesis to Another Level
  226. Nicotinamide Attenuates Focal Ischemic Brain Injury: Meta-Analysis or Mechanism of Protection
  227. Atheroma of the aortic arch: an important and poorly recognised factor in the aetiology of stroke
  228. Pooling of Animal Experimental Data Reveals Influence of Study Design and Publication Bias
  229. Media Watch
  230. Atheroma of the aortic arch: the missing link in the secondary prevention of stroke?
  231. Inequalities in the incidence and management of, and outcome from, neurological diseases in older people
  232. Mineralocorticoid receptor expression and increased survival following neuronal injury
  233. Effect of deprivation on time to hospital in acute stroke
  234. Reduced NMDA-induced apoptosis in neurons lacking ataxia telangiectasia mutated protein
  235. PubMed: http://www.pubmed.org
  236. Effect of deprivation and gender on the incidence and management of acute brain disorders
  237. What's a good doctor and how do you make one?
  238. Nitric-oxide-synthase-mediated cyclic guanosine monophosphate production in neonatal rat cerebellar prisms is resistant to calcineurin inhibition
  239. Serum withdrawal causes apoptosis in SHSY 5Y cells
  240. Caspase 6 activity initiates caspase 3 activation in cerebellar granule cell apoptosis
  241. The effect of tumour associated epilepsy on performance/handicap scales used in cerebral glioma
  242. Ischaemic heart disease and cholesterol There's more to heart disease than cholesterol